单剂遗传减毒疟原虫血液阶段寄生虫可交叉保护两种疟原虫感染
研究用靶向敲除NT1基因的遗传减毒伯氏疟原虫和约氏疟原虫混合冻存制剂,单次皮下接种小鼠,未引起可查见的血阶段感染,即对两种野生型疟原虫经静脉血阶段攻击产生完全保护。
要点
- 单次皮下接种两种遗传减毒nt1(-)疟原虫冻存混合剂未致可查见血阶段感染。
- 该接种对伯氏疟原虫ANKA株和约氏疟原虫17X-NL株攻击产生完全保护。
- 疟原虫NT1基因靶向缺失后需超生理浓度嘌呤才能生长。
核心结论
- 单次皮下接种亚可查见剂量的两种遗传减毒疟原虫可对两种疟原虫攻击产生完全保护。
研究设计与样本
- 研究在伯氏疟原虫和约氏疟原虫中靶向缺失NT1基因获得遗传减毒虫株。
- 将两种nt1(-)虫株等量混合冻存,以单次皮下剂量免疫小鼠。
- 免疫后用野生型伯氏疟原虫ANKA株和约氏疟原虫17X-NL株经静脉血阶段攻击。
主要发现
- 免疫后未出现可查见的血阶段感染。
- 免疫小鼠对伯氏疟原虫ANKA株和约氏疟原虫17X-NL株攻击均获得完全保护。
- Pfnt1(-)疟原虫仅在培养提供超生理浓度嘌呤后才能生长。
- 约氏疟原虫nt1(-)单次亚可查见剂量免疫可诱导同源血阶段攻击的完全保护,在免疫缺陷小鼠中仍保持亚可查见。
临床怎么用
- 作者认为,单次皮下亚可查见剂量的两种遗传减毒疟原虫有望在提供超生理浓度嘌呤的培养中制备,并以冻存剂量运送至流行区。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genetically-growth-attenuated blood-stage parasites were generated inPlasmodium falciparumby targeted deletion of NT1 (Nucleoside Transporter-1) gene, and Pfnt1(-) parasites only grew after providing the culture with supra-physiological concentrations of purines. Genetically-attenuatedP. yoeliint1(-)parasites induced sterile-protection against homologous blood-stage infectious challenge after immunization with single subpatent doses, which remained subpatent even in immune-compromised mice. Here, we showed that immunizations with frozen-stocks of equally-mixedP. bergheiandP. yoelii nt1(-)parasites in single subcutaneous doses, which did not lead to patent blood-stage infection, conferred sterile protection against intravenous infectious blood-stage challenge with wild-type parasites ofP. bergheiANKA andP. yoelii17X-NL strains. This data highlights the possibility that a single subcutaneous sub-patent dose of two species of genetically-growth-attenuated parasites, which can protect humans against twoPlasmodiumspp. infections, could be developed in cultures provided with supra-physiological concentrations of purines, and shipped to endemic areas as frozen-stock doses.
引用
- Deveci G, Kamil M, Aly ASI, et al. A single dose of genetically-attenuated malaria blood-stage parasites protects against two Plasmodium species infections. Vaccine. 2023. PMID: 36653222. doi:10.1016/j.vaccine.2023.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。